TiumBio Co. Ltd

TiumBio Co., Ltd. is a drug discovery company that researches and develops therapeutics for patients with unaddressed rare diseases. Its pipeline includes chemical entity-based drugs and biopharmaceuticals such as NCE401, NCE403, NCE406, and NBP604. The company has a collaboration agreement with Oncodesign Société Anonyme for research and development of fibrosis drug candidates. Founded in 2016, TiumBio is based in Seongnam-si, South Korea.